[HTML][HTML] Medicinal plants as sources of active molecules against COVID-19

B Benarba, A Pandiella - Frontiers in pharmacology, 2020 - frontiersin.org
The Severe Acute Respiratory Syndrome-related Coronavirus 2 (SARS-CoV-2) or novel
coronavirus (COVID-19) infection has been declared world pandemic causing a worrisome …

[HTML][HTML] Plants metabolites: possibility of natural therapeutics against the COVID-19 pandemic

FR Bhuiyan, S Howlader, T Raihan, M Hasan - Frontiers in medicine, 2020 - frontiersin.org
COVID-19, a disease induced by SARS-CoV-2 (Severe Acute Respiratory Syndrome
Coronavirus-2), has been the cause of a worldwide pandemic. Though extensive research …

In silico ADMET and molecular docking study on searching potential inhibitors from limonoids and triterpenoids for COVID-19

S Vardhan, SK Sahoo - Computers in biology and medicine, 2020 - Elsevier
Virtual screening of phytochemicals was performed through molecular docking, simulations,
in silico ADMET and drug-likeness prediction to identify the potential hits that can inhibit the …

Botanical drugs and supplements affecting the immune response in the time of COVID‐19: Implications for research and clinical practice

T Brendler, A Al‐Harrasi, R Bauer… - Phytotherapy …, 2021 - Wiley Online Library
In times of health crisis, including the current COVID‐19 pandemic, the potential benefit of
botanical drugs and supplements emerges as a focus of attention, although controversial …

[HTML][HTML] Promising antiviral activities of natural flavonoids against SARS-CoV-2 targets: systematic review

R Kaul, P Paul, S Kumar, D Büsselberg… - International journal of …, 2021 - mdpi.com
The ongoing COVID-19 pandemic, caused by the severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) became a globally leading public health concern over the past …

[HTML][HTML] In-silico evaluation of bioactive compounds from tea as potential SARS-CoV-2 nonstructural protein 16 inhibitors

R Singh, VK Bhardwaj, J Sharma, R Purohit… - Journal of traditional and …, 2022 - Elsevier
Background and aim A novel coronavirus, called the severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) has been found to cause COVID-19 in humans and some …

[HTML][HTML] Calendulaglycoside A showing potential activity against SARS-CoV-2 main protease: Molecular docking, molecular dynamics, and SAR studies

AA Zaki, A Ashour, SS Elhady, KM Darwish… - Journal of traditional and …, 2022 - Elsevier
Background and aim The discovery of drugs capable of inhibiting SARS-CoV-2 is a priority
for human beings due to the severity of the global health pandemic caused by COVID-19. To …

[HTML][HTML] Mushroom-derived bioactive compounds potentially serve as the inhibitors of SARS-CoV-2 main protease: An in silico approach

P Rangsinth, C Sillapachaiyaporn, S Nilkhet… - Journal of traditional and …, 2021 - Elsevier
Abstract Background and aim Coronavirus Disease 2019 (COVID-19) caused by severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has now become the world …

An overview of the anti-SARS-CoV-2 properties of Artemisia annua, its antiviral action, protein-associated mechanisms, and repurposing for COVID-19 treatment

AD Fuzimoto - Journal of integrative medicine, 2021 - Elsevier
Artemisia annua and its phytocompounds have a rich history in the research and treatment
of malaria, rheumatoid arthritis, systemic lupus erythematosus, and other diseases …

[HTML][HTML] Will curcumin nanosystems be the next promising antiviral alternatives in COVID-19 treatment trials?

D Dourado, DT Freire, DT Pereira… - Biomedicine & …, 2021 - Elsevier
The COVID-19 has become of striking interest since the number of deaths is constantly
rising all over the globe, and the search for an efficient treatment is more urgent. In light of …